Teva 5.125% 2029 bond (US88167AAQ40)
As of 2026-10-27 · rebuilt daily
https://bondscovery.com/bond/US88167AAQ40
Teva's 5.125% USD bond maturing 2029-05-09 (US88167AAQ40) yields 5.46% to worst as of 2026-10-27. That is 71 bp over the US Treasury curve at its call date and 27 bp above the fitted US A–BBB Healthcare & Pharmaceuticals Corporate Bond (USD) curve.
Against its curves
Each curve's fitted yield at this bond's maturity (at its call date, where it is priced to call), and the bond's spread to it.
| Curve | Curve yield | Spread |
|---|---|---|
| US Treasury Yields | 4.75% | +71 bp |
| Teva Bond Yields (USD) | 5.17% | +29 bp |
| US A–BBB Healthcare & Pharmaceuticals Corporate Bond Yields (USD) | 5.19% | +27 bp |
| US Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD) | 5.17% | +29 bp |
| US A–BBB Corporate Bond Yields (USD) | 5.31% | +15 bp |
| US Investment Grade Corporate Bond Yields (USD) | 5.30% | +16 bp |
The bond
| ISIN | US88167AAQ40 |
|---|---|
| Issuer | Teva |
| Issuer type | Corporate |
| Country | Israel |
| Sector | Healthcare & Pharmaceuticals |
| Currency | USD |
| Coupon | 5.125% |
| Coupon frequency | Semiannual |
| Maturity | 2029-05-09 |
| Next call | 2029-02-09 |
| Rating band | A+–BBB- (Investment Grade) |
| Yield to worst | 5.46% |
| Priced to | call on 2029-05-09 |